Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection

By Ferrer-Batallé Montserrat   Llop Esther   Ramírez Manel   Aleixandre Rosa Núria   Saez Marc   Comet Josep   de Llorens Rafael   Peracaula Rosa  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 845-845

MDPI

Access to resources Recommend Favorite

Current Status of Biomarkers for Prostate Cancer

By Velonas Vicki M.   Woo Henry H.   dos Remedios Cristobal G.   Assinder Stephen J.  

International Journal of Molecular Sciences, Vol. 14, Iss. 6, 2013-05 ,pp. : 11034-11060

MDPI

Access to resources Recommend Favorite

Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker

By Ravegnini Gloria   Zolezzi Moraga Juan Manuel   Maffei Francesca   Musti Muriel   Zenesini Corrado   Simeon Vittorio   Sammarini Giulia   Festi Davide   Hrelia Patrizia   Angelini Sabrina  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 28486-28497

MDPI

Access to resources Recommend Favorite

Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer

By Garajová Ingrid   Ferracin Manuela   Porcellini Elisa   Palloni Andrea   Abbati Francesca   Biasco Guido   Brandi Giovanni  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1547-1547

MDPI

Access to resources Recommend Favorite

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?

By Toss Angela   Venturelli Marta   Peterle Chiara   Piacentini Federico   Cascinu Stefano   Cortesi Laura  

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 85-85

MDPI

Access to resources Recommend Favorite